Literature DB >> 8959675

Second primary lung cancer in Flanders: frequency, clinical presentation, treatment and prognosis.

J Van Meerbeeck1, J Weyler, A Thibaut, J Vansteenkiste, J Aumann, G Deneffe, D Galdermans, M Haelterman, G Joos, M Noppen, P Pinson, J Tasson, A van den Eeckhout, M Uydebrouck.   

Abstract

Patient and tumour characteristics of 23 patients presenting with a second primary lung cancer were analysed and compared with 534 patients with radically resected stage 1 non-small cell lung cancer (NSCLC). None of these characteristics is associated with a higher occurrence rate for second primary lung cancer. Prognosis in the latter patients is significantly worse than after resection of a 'solitary' NSCLC: the median survival time (MST) after resection of the first tumour is 50 months; after diagnosis of the second tumour only 14 months. Surgically retreated patients have a prognosis that is similar to that after resection of a 'solitary' NSCLC. No separate independent prognostic factors responsible for this survival difference could be isolated. Squamous histology and central location are associated with a longer recurrence free survival time. We conclude that the occurrence of a second primary lung cancer can not be predicted based on patient or tumour characteristics and that only surgical retreatment offers a chance of long survival in these patients.

Entities:  

Mesh:

Year:  1996        PMID: 8959675     DOI: 10.1016/0169-5002(95)00593-5

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  6 in total

1.  Extremely Didactic Experience About the Postoperative Recurrence of Lung Cancer: a Case Report.

Authors:  Taiji Kuwata; Akihiro Taira; Yusuke Nabe; Shuichi Shinohara; Fumihiro Tanaka
Journal:  Indian J Surg Oncol       Date:  2018-04-30

2.  Performance of a rule-based semi-automated method to optimize chart abstraction for surveillance imaging among patients treated for non-small cell lung cancer.

Authors:  Catherine Byrd; Ureka Ajawara; Ryan Laundry; John Radin; Prasha Bhandari; Ann Leung; Summer Han; Stephen M Asch; Steven Zeliadt; Alex H S Harris; Leah Backhus
Journal:  BMC Med Inform Decis Mak       Date:  2022-06-03       Impact factor: 3.298

3.  Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma.

Authors:  R Taylor Ripley; Robert R McMillan; Camelia S Sima; Saad M Hasan; Usman Ahmad; Feiran Lou; David R Jones; Valerie W Rusch; Nabil P Rizk; James Huang
Journal:  Ann Thorac Surg       Date:  2014-07-16       Impact factor: 4.330

4.  Imaging surveillance and survival for surgically resected non-small-cell lung cancer.

Authors:  Leah M Backhus; Farhood Farjah; Chao-Kang Jason Liang; Hao He; Thomas K Varghese; David H Au; David R Flum; Steven B Zeliadt
Journal:  J Surg Res       Date:  2015-06-25       Impact factor: 2.192

5.  Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis.

Authors:  Jad Saab; Hamid Zia; Susan Mathew; Michael Kluk; Navneet Narula; Helen Fernandes
Journal:  Transl Oncol       Date:  2017-04-25       Impact factor: 4.243

6.  Intraoperative Diagnosis and Surgical Procedure with Imprint Cytology for Small Pulmonary Adenocarcinoma.

Authors:  Tomoyuki Nakagiri; Tomio Nakayama; Toshiteru Tokunaga; Akemi Takenaka; Hidenori Kunoh; Hiroto Ishida; Yasuhiko Tomita; Shin-Ichi Nakatsuka; Harumi Nakamura; Jiro Okami; Masahiko Higashiyama
Journal:  J Cancer       Date:  2020-02-20       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.